Has Leigh Ann Childress received payments from drug or device companies?

Yes. Drug and device makers reported $240,500 in general payments to Leigh Ann Childress across 704 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Leigh Ann Childress did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Leigh Ann Childress come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Leigh Ann Childress

Family · Huntsville, ALNPI 1700104189

Payments from drug & device makers

$240,500in general payments, 2019–2025

Across 704 payments — averaging $341.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$172K
Seagen Inc.$25K
Amgen$23K
Pfizer$4K
Daiichi Sankyo Inc.$4K
TG Therapeutics, Inc.$3K
plus $10K from 52 others

What the payments were for

Consulting fees$2,8731%
Speaking & faculty fees$190,00579%
Travel & lodging$29,40612%
Food & beverage$17,9997%
Education$2170%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	293	$171,950
Seagen Inc.	87	$25,359
Amgen	56	$22,583
Pfizer	26	$4,392
Daiichi Sankyo Inc.	25	$3,839
TG Therapeutics, Inc.	9	$2,623
Merck	9	$1,653
Genmab U.S., Inc.	6	$995
Sobi, Inc	2	$633
Janssen Scientific Affairs, LLC	8	$626
Novartis	28	$542
Epizyme, Inc.	1	$495
Beigene USA, Inc.	4	$413
Johnson & Johnson	14	$402
Gilead(2 entities)	12	$374
Sanofi	9	$341
Eisai Inc.	5	$262
Genentech USA, Inc.	3	$250
Genentech, Inc.	3	$222
Blueprint Medicines Corporation	4	$196
Bristol Myers Squibb	9	$183
AbbVie	3	$144
E.r. Squibb & Sons, L.L.C.	8	$140
Pharmacosmos Therapeutics Inc.	2	$127
Supernus Pharmaceuticals, Inc.	1	$125
Takeda Pharmaceuticals U.S.A., Inc.	4	$115
Array Biopharma Inc	5	$106
Incyte Corporation	5	$103
Puma Biotechnology, Inc.	6	$101
Pharmacyclics LLC, An Abbvie Company	5	$95
Regeneron Healthcare Solutions, Inc.	5	$86
Karyopharm Therapeutics Inc.	4	$72
Springworks Therapeutics, Inc.	4	$71
Sanofi-aventis U.S. LLC	1	$68
Iovance Biotherapeutics, Inc.	3	$68
Jazz Pharmaceuticals Inc.	1	$61
Coherus Oncology, Inc.	3	$61
GSK	2	$55
Stemline Therapeutics Inc.	2	$51
Pharmaessentia USA Corporation	2	$40
AVEO Pharmaceuticals, Inc.	2	$39
Lilly USA, LLC	2	$38
Exelixis Inc.	2	$38
Boehringer Ingelheim	2	$36
Acrotech Biopharma Inc.	2	$35
Progenics Pharmaceuticals, Inc.	1	$35
Deciphera Pharmaceuticals Inc.	2	$32
Bayer	2	$31
Mirati Therapeutics, Inc.	1	$29
Sumitomo Pharma America, Inc.	1	$25
CTI Biopharma Corp.	1	$20
Ipsen Biopharmaceuticals, Inc	1	$20
Rigel Pharmaceuticals, Inc.	1	$20
Tersera Therapeutics LLC	1	$19
Agios Pharmaceuticals, Inc.	1	$18
Myriad Genetic Laboratories, Inc.	1	$18
Global Blood Therapeutics, Inc.	1	$13
EMD Serono, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LYNPARZA$49,565
TAGRISSO$28,901
TUKYSA$28,272
IMFINZI$22,555
CALQUENCE$20,292
Kyprolis$19,365
DATROWAY$9,000
UKONIQ$1,526
KEYTRUDA$1,515
EPKINLY$853
DOPTELET$600
BRUKINSA$350
Enhertu$332
Columvi$312
RYBREVANT$290
TECVAYLI$290
AKEEGA$290
Erleada$290
Lunsumio$210
POLIVY$210

How this compares

$240,500 in reported general payments places this provider in the 95th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama →

Medicare billing

Part B allowed, 2024

$42,072

Medicare patients

Services billed

1,965

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Huntsville

Christina CanteyHuntsville$118K
Julia BettsHuntsville$27K
Joann IkardHuntsville$19K
Hannah GarnettHuntsville$18K
Alyssa FikesHuntsville$15K
Justin WilsonCullman$1.1M
Molly ReevesAuburn$158K
Leigh LunaMontgomery$69K
Christopher LovellMobile$64K
Justin SimpsonTuscaloosa$43K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →